BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 29415044)

  • 1. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data.
    Favero F; Joshi T; Marquard AM; Birkbak NJ; Krzystanek M; Li Q; Szallasi Z; Eklund AC
    Ann Oncol; 2015 Jan; 26(1):64-70. PubMed ID: 25319062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and clinical application of an integrative genomic approach to personalized cancer therapy.
    Uzilov AV; Ding W; Fink MY; Antipin Y; Brohl AS; Davis C; Lau CY; Pandya C; Shah H; Kasai Y; Powell J; Micchelli M; Castellanos R; Zhang Z; Linderman M; Kinoshita Y; Zweig M; Raustad K; Cheung K; Castillo D; Wooten M; Bourzgui I; Newman LC; Deikus G; Mathew B; Zhu J; Glicksberg BS; Moe AS; Liao J; Edelmann L; Dudley JT; Maki RG; Kasarskis A; Holcombe RF; Mahajan M; Hao K; Reva B; Longtine J; Starcevic D; Sebra R; Donovan MJ; Li S; Schadt EE; Chen R
    Genome Med; 2016 Jun; 8(1):62. PubMed ID: 27245685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel machine learning approach (svmSomatic) to distinguish somatic and germline mutations using next-generation sequencing data.
    Mao YF; Yuan XG; Cun YP
    Zool Res; 2021 Mar; 42(2):246-249. PubMed ID: 33709636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting statistical interaction between somatic mutational events and germline variation from next-generation sequence data.
    Hu H; Huff CD
    Pac Symp Biocomput; 2014; ():51-62. PubMed ID: 24297533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-FIT: allele-frequency-based imputation of tumor purity from high-depth sequencing data.
    Loh JW; Guccione C; Di Clemente F; Riedlinger G; Ganesan S; Khiabanian H
    Bioinformatics; 2020 Apr; 36(7):2173-2180. PubMed ID: 31750888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short and long-read genome sequencing methodologies for somatic variant detection; genomic analysis of a patient with diffuse large B-cell lymphoma.
    Roberts HE; Lopopolo M; Pagnamenta AT; Sharma E; Parkes D; Lonie L; Freeman C; Knight SJL; Lunter G; Dreau H; Lockstone H; Taylor JC; Schuh A; Bowden R; Buck D
    Sci Rep; 2021 Mar; 11(1):6408. PubMed ID: 33742045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotype-resolved germline and somatic alterations in renal medullary carcinomas.
    Tan KT; Kim H; Carrot-Zhang J; Zhang Y; Kim WJ; Kugener G; Wala JA; Howard TP; Chi YY; Beroukhim R; Li H; Ha G; Alper SL; Perlman EJ; Mullen EA; Hahn WC; Meyerson M; Hong AL
    Genome Med; 2021 Jul; 13(1):114. PubMed ID: 34261517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.
    Li X; Kumar S; Harmanci A; Li S; Kitchen RR; Zhang Y; Wali VB; Reddy SM; Woodward WA; Reuben JM; Rozowsky J; Hatzis C; Ueno NT; Krishnamurthy S; Pusztai L; Gerstein M
    Genome Med; 2021 Apr; 13(1):70. PubMed ID: 33902690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort.
    Vanni I; Pastorino L; Andreotti V; Comandini D; Fornarini G; Grassi M; Puccini A; Tanda ET; Pastorino A; Martelli V; Mastracci L; Grillo F; Cabiddu F; Guadagno A; Coco S; Allavena E; Barbero F; Bruno W; Dalmasso B; Bellomo SE; Marchiò C; Spagnolo F; Sciallero S; Berrino E; Ghiorzo P
    J Transl Med; 2024 May; 22(1):462. PubMed ID: 38750555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations.
    Sprissler R; Perkins B; Johnstone L; Babiker HM; Chalasani P; Lau B; Hammer M; Mahadevan D
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32570879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somalier: rapid relatedness estimation for cancer and germline studies using efficient genome sketches.
    Pedersen BS; Bhetariya PJ; Brown J; Kravitz SN; Marth G; Jensen RL; Bronner MP; Underhill HR; Quinlan AR
    Genome Med; 2020 Jul; 12(1):62. PubMed ID: 32664994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequencing paired tumor DNA and white blood cells improves circulating tumor DNA tracking and detects pathogenic germline variants in localized colon cancer.
    Gimeno-Valiente F; Martín-Arana J; Tébar-Martínez R; Gambardella V; Martínez-Ciarpaglini C; García-Micó B; Martínez-Castedo B; Palomar B; García-Bartolomé M; Seguí V; Huerta M; Moro-Valdezate D; Pla-Martí V; Pérez-Santiago L; Roselló S; Roda D; Cervantes A; Tarazona N
    ESMO Open; 2023 Dec; 8(6):102051. PubMed ID: 37951129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline contamination and leakage in whole genome somatic single nucleotide variant detection.
    Sendorek DH; Caloian C; Ellrott K; Bare JC; Yamaguchi TN; Ewing AD; Houlahan KE; Norman TC; Margolin AA; Stuart JM; Boutros PC
    BMC Bioinformatics; 2018 Jan; 19(1):28. PubMed ID: 29385983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep whole-genome sequencing of 3 cancer cell lines on 2 sequencing platforms.
    Arora K; Shah M; Johnson M; Sanghvi R; Shelton J; Nagulapalli K; Oschwald DM; Zody MC; Germer S; Jobanputra V; Carter J; Robine N
    Sci Rep; 2019 Dec; 9(1):19123. PubMed ID: 31836783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen.
    Marquard AM; Birkbak NJ; Thomas CE; Favero F; Krzystanek M; Lefebvre C; Ferté C; Jamal-Hanjani M; Wilson GA; Shafi S; Swanton C; André F; Szallasi Z; Eklund AC
    BMC Med Genomics; 2015 Oct; 8():58. PubMed ID: 26429708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ancestry and frequency of genetic variants in the general population are confounders in the characterization of germline variants linked to cancer.
    Bobyn A; Zarrei M; Zhu Y; Hoffman M; Brenner D; Resnick AC; Scherer SW; Gallo M
    BMC Med Genet; 2020 May; 21(1):92. PubMed ID: 32375678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data.
    do Valle ÍF; Giampieri E; Simonetti G; Padella A; Manfrini M; Ferrari A; Papayannidis C; Zironi I; Garonzi M; Bernardi S; Delledonne M; Martinelli G; Remondini D; Castellani G
    BMC Bioinformatics; 2016 Nov; 17(Suppl 12):341. PubMed ID: 28185561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute quantification of somatic DNA alterations in human cancer.
    Carter SL; Cibulskis K; Helman E; McKenna A; Shen H; Zack T; Laird PW; Onofrio RC; Winckler W; Weir BA; Beroukhim R; Pellman D; Levine DA; Lander ES; Meyerson M; Getz G
    Nat Biotechnol; 2012 May; 30(5):413-21. PubMed ID: 22544022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multiethnic Germline-Somatic Association Database Deciphers Multilayered and Interconnected Genetic Mutations in Cancer.
    Xin J; Mo Z; Chai R; Hua W; Wang J
    Cancer Res; 2024 Feb; 84(3):364-371. PubMed ID: 38016109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.